Newsroom Stories

Hillary A. Sale, JD, securities law expert and professor of law at Washington University in St. Louis, talks with Steve Chiotakis of Marketplace Public Radio about whether it’s difficult to prosecute derivatives trading and what she’s watching closely about cases coming down the pike.

Liviu Mirica, PhD, assistant professor of chemistry in Arts & Sciences, and Yinjie Tang, PhD, assistant professor of chemical engineering, receive Ralph E. Powe Junior Faculty Achievement Awards on June 14 from Chancellor Mark S. Wrighton.

Sports updates for the month of July 2010.

School of Medicine employees were honored June 11 for their years of service.

Classic vs. contemporary, emerging vs. established, traditional vs. cutting-edge. Every year, the Edison OVATIONS Series bridges such dichotomies with groundbreaking presentations by some of today’s most critically acclaimed performing artists. The 2010-11 season will feature a range of innovative events, from Philip Glass’ modern take on Antonio Vivaldi to uproarious re-conceptions of works by William Shakespeare and Mary Shelley.  

Philip E. Cryer, MD, will receive the American Diabetes Association’s Albert Renold Award at the organization’s 70th Scientific Sessions in Orlando, Fla. The Albert Renold Award is presented to an individual whose career is distinguished by outstanding achievements in the training of diabetes research scientists and the facilitation of diabetes research. 

Three employees at Washington University School of Medicine were recently honored by Larry Shapiro, MD, executive vice chancellor for medical affairs and dean of the School of Medicine, for outstanding service, commitment and dedication to the medical school.

Jonathan M. Green, MD, has been named associate dean for human studies and executive chair of the Institutional Review Board (IRB) at Washington University in St. Louis.

Recycling at the School of Medicine is about to get easier. Most recyclable items will be able to be placed in the same container throughout the School of Medicine starting July 1

The diabetes drug rosiglitazone has been under intense scrutiny since a 2007 study in the New England Journal of Medicine looked at more than 40 clinical trials and linked the drug’s use with increased risk of heart attack and death from heart disease.